prostate cancer

Are Takeover Talk and Provenge Adding Optimism to Dendreon’s Biggest Institutional Shareholders?

Are Takeover Talk and Provenge Adding Optimism to Dendreon’s Biggest Institutional Shareholders?

Wall St. Cheat Sheet

[video]The Drama's Not Over at Dendreon

[video]The Drama's Not Over at Dendreon

Motley Fool

Dendreon does not see choice between Provenge and Jevtana/Zytiga as 'either/or'

Dendreon does not see choice between Provenge and Jevtana/Zytiga as 'either/or'

Yahoo/Fly on the Wall

Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug

Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug

Seeking Alpha

OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up

OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up

Xconomy

Bellicum snags $20M for mid-stage cancer vaccine program

Bellicum snags $20M for mid-stage cancer vaccine program

Fierce Biotech

J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation

J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation

TheStreet.com

In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll

In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll

Seeking Alpha

Exelixis announces initiation of trial combining cabozantinib, abiraterone

Exelixis announces initiation of trial combining cabozantinib, abiraterone

Yahoo/Fly on the Wall

Dendreon: Overall Survival Data For Provenge From 2012 GU Poster

Dendreon: Overall Survival Data For Provenge From 2012 GU Poster

Seeking Alpha